Receptor variation influences fingolimod efficacy in mouse multiple sclerosis models

(JCI Journals) In this issue of JCI Insight, May Han of Stanford University and colleagues tested the hypothesis that genetic variants of the cell surface receptor that responds to S1P, S1PR1, may influence the efficacy of fingolimod.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news